cancer research

Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients With Rare Genetic Mutations to Targeted Therapy

First companion diagnostic claim for Illumina's TruSight™ Oncology Comprehensive (EU) test enables targeted therapy with Bayer's VITRAKVI® (larotrectinib) for patients with NTRK fusion cancer
Press Release

SAN DIEGO, May 24, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.

Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care

Study will evaluate whether blood-based testing can inform oncology providers about genetic variations within a patient's cancer, which may influence choice of treatment based on cancer stage and type
Press Release

SAN DIEGO, May 18, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, and Allegheny Health Network (AHN), an integrated health system serving the Western Pennsylvania area, today announced a collaboration to evaluate the impact of in-house comprehensive genomic profiling (CGP) to enhance patient care.

Alkermes Spotlights Cancer Research

Multimedia with summary

While coping with the effects of cancer during the holidays is difficult, we find hope in the research work being done at Alkermes to help expand the future of cancer treatment for patients and their families.

Carnival Cruise Line Reaffirms Commitment to St. Jude Children’s Research Hospital®, Increases Pledge to $33 Million by 2024

Press Release

MIAMI, September 27, 2019 /3BL Media/ – Reaffirming its longstanding commitment to St. Jude Children’s Research Hospital®, Carnival Cruise Line has announced that it will raise its pledge to a total of $33 million by 2024. 

In Effort to Support Childhood Cancer Research, Aflac Addresses Facebook’s Algorithm Change

Insurer took steps to ensure its messages found their way into users’ newsfeeds.
Article

Recent efforts have resulted in Aflac winning first place in the “Use of Facebook” category of PR Daily’s 2019 Digital Marketing & Social Media Awards.

Read more

Aflac Donates $1.5 Million for Childhood Cancer Research and Meets Their 2018 Giving Goal

Multimedia with summary

September was Childhood Cancer Awareness Month, and Aflac wants to give a big THANK YOU for using #Duckprints on social media.

Bristol-Myers Squibb Kicks Off Coast 2 Coast 4 Cancer Ride to Fundraise for the V Foundation for Cancer Research

More than 100 company employees will ride across the country with the goal of raising $1 million for cancer research
Press Release

PRINCETON, N.J., September 5, 2018 /3BL Media/ -- Today, for the fifth year in a row, Bristol-Myers Squibb Company (NYSE:BMY) is launching 

eBay and ESPN Support Cancer Research With the 14th Annual ESPY Day Auction

This year, the partnership raised $650,000 in support of the V Foundation for Cancer Research
Article

For more than a decade, eBay and ESPN have partnered to host an annual ESPY Awards Charity Campaign in support of the V Foundation, an organization that creates an urgent awareness among all Americans of the importance on the war against cancer through education, advocacy, fundraising and philanthropy.

Team ScottsMiracle-Gro is Ready to Ride Through Central Ohio

ScottsMiracle-Gro associates are participating in Pelotonia’s 10th anniversary ride.
Blog

ScottsMiracle-Gro has a long tradition of giving back to the community. Most often, this is done by associates volunteering for a variety of nonprofit organizations. One of our associate groups, however, is making a difference by bicycling.

All Good, All Year Pedals on with Cycle for Survival Fundraiser

by Michael Valentino
Blog

Another year, another Team Viacom success story.

In a continuing tradition central to Viacommunity’s All Good, All Year initiative, 24 Team Viacom employees in  New York and Los Angeles joined the battle to beat rare cancers by participating in Cycle for Survival’s 12th year of rides, helping to raise some of the more than $40 million in critical funds that the organization has raised for rare cancer research this season alone.

Pages

Subscribe to cancer research